• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

起源于十二指肠型滤泡性淋巴瘤共同起源的非生发中心弥漫性大B细胞淋巴瘤。

Non-germinal center diffuse large B-cell lymphoma arising from a common origin of duodenal-type follicular lymphoma.

作者信息

Kubo Tomoyo, Nagai Yuya, Shimomura Yoshimitsu, Kamijo Kimimori, Shiroishi Yumi, Maruoka Hayato, Yamashita Daisuke, Ishikawa Takayuki

机构信息

Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.

Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe Japan.

出版信息

J Clin Exp Hematop. 2025 Jun 28;65(2):135-139. doi: 10.3960/jslrt.25009. Epub 2025 Apr 30.

DOI:10.3960/jslrt.25009
PMID:40301080
Abstract

Duodenal-type follicular lymphoma (DFL) is a rare subtype of follicular lymphoma (FL) characterized by a remarkably indolent clinical course. However, histological transformation to diffuse large B-cell lymphoma (DLBCL) has been sporadically reported, and its clinicopathological features remain poorly understood. We describe a rare case of DFL that transformed to non-germinal center DLBCL, including the specific biological characteristics based on immunohistochemical, cytogenetic, and molecular analyses. A 62-year-old woman was diagnosed with DFL and followed without treatment. Six years later, she presented with progressive anemia and an ulcerative lesion in the ileocecum. Biopsy confirmed the diagnosis of DLBCL with the non-GCB immunophenotype according to Hans' algorithm, which is an uncommon immunophenotype of transformed FL. Fluorescence in situ hybridization analysis revealed BCL6 translocation in both DFL and DLBCL samples. In addition, polymerase chain reaction and sequencing analyses of immunoglobulin heavy and light chain rearrangements clearly demonstrated that the DFL and DLBCL share a common origin. After surgical resection of the ileocecal lesion and six cycles of R-CHOP chemotherapy, the patient has remained in complete remission for 3 years. This case highlights the importance of long-term follow-up of DFL and provides insights into the pathophysiology underlying the transformation of DFL.

摘要

十二指肠型滤泡性淋巴瘤(DFL)是滤泡性淋巴瘤(FL)的一种罕见亚型,其临床病程极为惰性。然而,向弥漫性大B细胞淋巴瘤(DLBCL)的组织学转化虽有零星报道,但其临床病理特征仍知之甚少。我们描述了一例罕见的DFL转化为非生发中心DLBCL的病例,包括基于免疫组化、细胞遗传学和分子分析的特定生物学特征。一名62岁女性被诊断为DFL,未接受治疗并进行随访。六年后,她出现进行性贫血和回盲部溃疡性病变。活检根据汉斯算法确诊为具有非生发中心B细胞免疫表型的DLBCL,这是转化型FL一种不常见的免疫表型。荧光原位杂交分析显示DFL和DLBCL样本中均存在BCL6易位。此外,免疫球蛋白重链和轻链重排的聚合酶链反应及测序分析清楚地表明DFL和DLBCL起源相同。在回盲部病变手术切除及六个周期的R-CHOP化疗后,患者已完全缓解3年。该病例突出了DFL长期随访的重要性,并为DFL转化的病理生理学提供了见解。

相似文献

1
Non-germinal center diffuse large B-cell lymphoma arising from a common origin of duodenal-type follicular lymphoma.起源于十二指肠型滤泡性淋巴瘤共同起源的非生发中心弥漫性大B细胞淋巴瘤。
J Clin Exp Hematop. 2025 Jun 28;65(2):135-139. doi: 10.3960/jslrt.25009. Epub 2025 Apr 30.
2
Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.利妥昔单抗作为 III-IV 期滤泡性淋巴瘤的一线治疗药物(对技术评估第 110 号的回顾):一项系统评价和经济评估。
Health Technol Assess. 2012;16(37):1-253, iii-iv. doi: 10.3310/hta16370.
3
Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation.利妥昔单抗(美罗华)治疗侵袭性非霍奇金淋巴瘤:系统评价与经济学评估
Health Technol Assess. 2004 Sep;8(37):iii, ix-xi, 1-82. doi: 10.3310/hta8370.
4
Treating newly diagnosed Diffuse Large B-cell Lymphoma in the elderly patient with R-mini-CHOP: A single centre analytical retrospective observational study.用R-mini-CHOP方案治疗老年新诊断弥漫性大B细胞淋巴瘤:一项单中心分析性回顾性观察研究。
Med J Malaysia. 2025 May;80(3):307-312.
5
Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era.在利妥昔单抗时代滤泡性淋巴瘤和弥漫性大 B 细胞淋巴瘤成分共存患者的临床特征和预后。
J Cancer Res Clin Oncol. 2023 Jun;149(6):2311-2318. doi: 10.1007/s00432-022-04381-8. Epub 2022 Oct 11.
6
The efficacy and safety of ZR2 versus R-CHOP-like for elderly patients with newly diagnosed diffuse large B cell lymphoma: a single-center prospective study in China.ZR2与类R-CHOP方案治疗新诊断老年弥漫性大B细胞淋巴瘤的疗效及安全性:中国一项单中心前瞻性研究
Ann Hematol. 2025 Jan;104(1):605-615. doi: 10.1007/s00277-024-06066-3. Epub 2024 Oct 30.
7
DA-EPOCH-R improves the outcome over that of R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high-risk IPI, but not for double expressor lymphoma.DA-EPOCH-R 方案可改善 60 岁以下、生发中心 B 细胞型(GCB)表型和高危国际预后指数(IPI)的弥漫性大 B 细胞淋巴瘤(DLBCL)患者的预后,但其对双表达淋巴瘤无效。
J Cancer Res Clin Oncol. 2019 Jan;145(1):117-127. doi: 10.1007/s00432-018-2771-9. Epub 2018 Oct 16.
8
Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia.苯达莫司汀用于治疗惰性B细胞淋巴瘤患者,包括慢性淋巴细胞白血病。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009045. doi: 10.1002/14651858.CD009045.pub2.
9
[Prognostic factors in elderly patients with diffuse large B-cell lymphoma and their treatment results.].[老年弥漫性大B细胞淋巴瘤患者的预后因素及其治疗结果。]
Adv Gerontol. 2025;38(2):236-242.
10
Rituximab induced lung injury.利妥昔单抗诱发的肺损伤。
BMC Pulm Med. 2025 Jul 28;25(1):359. doi: 10.1186/s12890-025-03802-x.

本文引用的文献

1
Clinical features and outcomes of duodenal-type follicular lymphoma: A single-center retrospective study.十二指肠型滤泡性淋巴瘤的临床特征与预后:一项单中心回顾性研究
EJHaem. 2022 Jan 31;3(2):379-384. doi: 10.1002/jha2.384. eCollection 2022 May.
2
Development of diffuse large B-cell lymphoma from duodenal type follicular lymphoma: a retrospective study of 23 cases.十二指肠型滤泡性淋巴瘤转化为弥漫性大B细胞淋巴瘤:23例回顾性研究
Int J Hematol. 2020 Nov;112(5):658-665. doi: 10.1007/s12185-020-02957-z. Epub 2020 Aug 1.
3
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups.
现代滤泡性淋巴瘤:生存、治疗结果和高危亚组的识别。
Blood Cancer J. 2020 Jul 17;10(7):74. doi: 10.1038/s41408-020-00340-z.
4
IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution.IGHV 测序揭示了滤泡性淋巴瘤演进过程中获得的 N-糖基化位点是一个克隆和稳定的事件。
Blood. 2020 Mar 12;135(11):834-844. doi: 10.1182/blood.2019002279.
5
What do we know about duodenal-type follicular lymphoma? From pathological definition to treatment options.我们对十二指肠型滤泡性淋巴瘤了解多少?从病理定义到治疗选择。
Br J Haematol. 2020 Mar;188(6):831-837. doi: 10.1111/bjh.16348. Epub 2019 Dec 27.
6
Histological transformation in duodenal-type follicular lymphoma: a case report and review of the literature.十二指肠型滤泡性淋巴瘤的组织学转化:一例病例报告及文献复习
Oncotarget. 2019 May 21;10(36):3424-3429.
7
Recent progress in follicular lymphoma in Japan and characteristics of the duodenal type.日本滤泡性淋巴瘤的最新进展及十二指肠型的特征
Pathol Int. 2018 Dec;68(12):665-676. doi: 10.1111/pin.12733. Epub 2018 Nov 20.
8
Cell of origin of transformed follicular lymphoma.转化性滤泡性淋巴瘤的起源细胞。
Blood. 2015 Oct 29;126(18):2118-27. doi: 10.1182/blood-2015-06-649905. Epub 2015 Aug 25.
9
A case of diffuse large B-cell lymphoma transformed from primary duodenal follicular lymphoma.一例由原发性十二指肠滤泡性淋巴瘤转化而来的弥漫性大B细胞淋巴瘤病例。
Pathol Int. 2014 Oct;64(10):527-32. doi: 10.1111/pin.12197. Epub 2014 Sep 3.
10
Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource.免疫化疗时代滤泡性淋巴瘤转化的发生率和结局:来自爱荷华大学/梅奥诊所卓越研究计划分子流行病学资源的报告。
J Clin Oncol. 2013 Sep 10;31(26):3272-8. doi: 10.1200/JCO.2012.48.3990. Epub 2013 Jul 29.